Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis

Clinical evidence demonstrates coadministration of tumour necrosis factor inhibitor (TNFi) agents and methotrexate (MTX) is more efficacious than administration of TNFi agents alone in patients with rheumatoid arthritis, leading to the perception that coadministration of MTX with all biologic agents...

Descripción completa

Detalles Bibliográficos
Autores principales: Emery, Paul, Sebba, Anthony, Huizinga, Tom W J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841743/
https://www.ncbi.nlm.nih.gov/pubmed/23918035
http://dx.doi.org/10.1136/annrheumdis-2013-203485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841743/
https://www.ncbi.nlm.nih.gov/pubmed/23918035
http://dx.doi.org/10.1136/annrheumdis-2013-203485

Ejemplares similares